Venture capital firm CHL Medical Partners leads B round for Vascular Pathways, a US-based medical device company also backed by Ascension Health Ventures.
Vascular Pathways, a US-based medical device company, has raised $14m in its series B round from a consortium including Ascension Health Ventures, the corporate venturing division of Ascension Health and Catholic healthcare organisations.
Venture capital firm CHL Medical Partners led the B round, with the other syndicate members including peers MVM Life Science Partners and Arcus Ventures. Walter Lin, investment manager at Ascension Health Ventures, has joined Vascular’s board, along with Myles Greenberg of CHL and Stephen Reeders of MVM.
…
